This is an aggregated industry headline. Read the full story at Drug Channels →
The Top Pharmacy Benefit Managers of 2025: Market Share and Key Industry Developments (rerun)
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. Click here to see the original post from March 2026. By Adam J. Fein, Ph.D.Three is still the magic number for pharmacy be
By Drug Channels
· Jun 9, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
The ad uses hand-crafted puppets to portray sight-based frustrations for those with presbyopia, a common condi…
The WeekFierceBiotech ↗
Roche's investigational KRAS G12C inhibitor has beaten Amgen's Lumakras and Bristol Myers Squibb's Krazati in …
The WeekBriefing
CMS is again proposing reduced Medicare payments for 340B drugs, reopening a long fight over hospital margins …